Oklo increases ATM capacity to $540M from $400M with new prospectus supplement

Oklo Inc.

Oklo files prospectus supplement to sell up to $540M of common stock; previously issued 5,458,953 shares for $400M gross proceeds.
Remaining capacity under new supplement is approximately $140M, sold via sales agreement with Goldman Sachs, BofA, B. Riley, TD Securities.
Prior prospectus supplement from June 10, 2025, is effectively replaced; no further offers will be made under it.
Shares registered under Form S-3 registration statement (File No. 333-287715) declared effective June 12, 2025.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.